Applied DNA Sciences Set to Join Russell Microcap Index
Applied DNA Sciences Inc. (NASDAQ: APDN) (Applied DNA or the Company) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, is set to join the Russell Microcap Index (the Index) at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the U.S. market opens on June 29, according to a preliminary list of additions posted on June 19 to the Russell Reconstitution website .
- Applied DNA Sciences Inc. (NASDAQ: APDN) (Applied DNA or the Company) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, is set to join the Russell Microcap Index (the Index) at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the U.S. market opens on June 29, according to a preliminary list of additions posted on June 19 to the Russell Reconstitution website .
- Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
- Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
- For more information on the Russell Microcap Index and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .